EUVIMEDEUVIMED entdecken
Crossref

Leveraging biomarkers and translational medicine for preclinical safety - Lessons for advancing the validation of alternatives to animal testing

Thomas Hartung, Nicholas M P King, Nicole Kleinstreuer, Marcel Leist, Danilo A Tagle

ALTEX · 2024 · 41 (4)

DOI: 10.14573/altex.2410011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ALTEX, 2024. Verfasst von Thomas Hartung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Alternatives to Animal Testing (CAAT), Doerenkamp-Zbinden-Chair for Evidence-based Toxicology, Johns Hopkins Bloomberg School of Public He…. Hauptthemen laut MEDLINE: Animal Testing Alternatives, Biomarkers, Translational Research, Biomedical. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Animal Testing AlternativesBiomarkersTranslational Research, BiomedicalAnimalsHumansDrug Evaluation, PreclinicalTranslational Science, Biomedical

Stichwörter der Autor:innen

new approach methodologiesalternative methodsartificial intelligencebiomarkersin vitro modelspreclinical safetyregulatory acceptancetranslational medicinetranslational researchtranslational science

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Center for Alternatives to Animal Testing (CAAT), Doerenkamp-Zbinden-Chair for Evidence-based Toxicology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • CAAT-Europe, University of Konstanz, Germany.
  • Critical Path Institute, Tucson, AZ, USA.
  • National Institute of Health, National Institute for Environmental Health Sciences, DTT/NICEATM, Durham, NC, USA.
  • CAAT-Europe, University of Konstanz, Germany; In vitro Toxicology and Biomedicine, University of Konstanz, Konstanz, Germany.
  • National Institute of Health, National Center for Advancing Translational Sciences (NCATS), Bethesda, MD, USA.

Zitieren

APA

Hartung, T., King, N. M. P., Kleinstreuer, N., Leist, M., & Tagle, D. A. (2024). Leveraging biomarkers and translational medicine for preclinical safety - Lessons for advancing the validation of alternatives to animal testing. ALTEX, 41(4). https://doi.org/10.14573/altex.2410011

Vancouver

Hartung T, King NMP, Kleinstreuer N, Leist M, Tagle DA. Leveraging biomarkers and translational medicine for preclinical safety - Lessons for advancing the validation of alternatives to animal testing. ALTEX. 2024;41(4). doi:10.14573/altex.2410011

BibTeX
@article{Hartung2024,
  author = {Hartung, Thomas and King, Nicholas M P and Kleinstreuer, Nicole and Leist, Marcel and Tagle, Danilo A},
  title = {Leveraging biomarkers and translational medicine for preclinical safety - Lessons for advancing the validation of alternatives to animal testing},
  journal = {ALTEX},
  year = {2024},
  volume = {41},
  number = {4},
  doi = {10.14573/altex.2410011}
}
Kostenlos starten →